China Generic Pharmaceuticals Market Size & Outlook

The generic pharmaceuticals market in China is expected to reach a projected revenue of US$ 33.0 million by 2028. A compound annual growth rate of 9.4% is expected of China generic pharmaceuticals market from 2021 to 2028.
Revenue, 2020 (US$M)
$16.1
Forecast, 2028 (US$M)
$33.0
CAGR, 2021 - 2028
9.4%
Report Coverage
China

China generic pharmaceuticals market highlights

  • The China generic pharmaceuticals market generated a revenue of USD 16.1 million in 2020 and is expected to reach USD 33.0 million by 2028.
  • The China market is expected to grow at a CAGR of 9.4% from 2021 to 2028.
  • In terms of segment, simple generic was the largest revenue generating type in 2020.
  • Biosimilars is the most lucrative type segment registering the fastest growth during the forecast period.


Generic pharmaceuticals market data book summary

Market revenue in 2020USD 16.1 million
Market revenue in 2028USD 33.0 million
Growth rate9.4% (CAGR from 2020 to 2028)
Largest segmentSimple generic
Fastest growing segmentBiosimilars
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationSimple Generic, Specialty Generics, Biosimilars
Key market players worldwideTeva Pharmaceutical Industries Ltd, Viatris Inc, Novartis AG ADR, Sun Pharmaceutical Industries, Lupin, AbbVie Inc, AstraZeneca PLC, Sawai Group Holdings Co Ltd, Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd ADR, Cipla Ltd DR, Sanofi SA, Aurobindo Pharma, Endo Pharmaceuticals


Other key industry trends

  • In terms of revenue, China accounted for 5.2% of the global generic pharmaceuticals market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Asia Pacific, Japan generic pharmaceuticals market is projected to lead the regional market in terms of revenue in 2028.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 42.4 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Generic Pharmaceuticals Market Companies

Name Profile # Employees HQ Website

China generic pharmaceuticals market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to generic pharmaceuticals market will help companies and investors design strategic landscapes.


Simple generic was the largest segment with a revenue share of 73.91% in 2020. Horizon Databook has segmented the China generic pharmaceuticals market based on simple generic, specialty generics, biosimilars covering the revenue growth of each sub-segment from 2018 to 2028.


Reasons to subscribe to China generic pharmaceuticals market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China generic pharmaceuticals market databook

  • Our clientele includes a mix of generic pharmaceuticals market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China generic pharmaceuticals market , including forecasts for subscribers. This country databook contains high-level insights into China generic pharmaceuticals market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China generic pharmaceuticals market size, by type, 2018-2028 (US$M)

China Generic Pharmaceuticals Market Outlook Share, 2020 & 2028 (US$M)

China generic pharmaceuticals market size, by type, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more